HomeAI · summaries
Storia in 19 fonti
STUDIU: Un nou medicament dublează perioada de supraviețuire pentru pacienții diagnosticați cu cancer pancreatic
S-a descoperit că o pastilă poate aproape dubla perioada de supraviețuire pentru pacienții cu cancer pancreatic avansat, experții descriind studiul clinic ca fiind revoluționar.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
- ·
independent.co.uk
Daily pill almost doubles survival time for pancreatic cancer patients in new trial
Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease
- ·
theguardian.com
Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer
- ·
dailymail.com
New drug gives extra months of life to pancreatic cancer patients
Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.
- ·
Pancreatic cancer breakthrough as pill almost doubles survival time for patients
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…
- ·
tg24.sky.it
Tumore al pancreas, studio: un nuovo farmaco allunga la sopravvivenza
Leggi su Sky TG24 l'articolo Tumore al pancreas, un nuovo farmaco sperimentale aumenta la sopravvivenza. Lo studio
- ·
cbsnews.com
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
- ·
fortune.com
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…
- ·
adnkronos.com
Cancro al pancreas, un farmaco raddoppia il periodo di sopravvivenza: "Nuova strada"
Nello studio condotto su 500 pazienti, tutti affetti da cancro al pancreas metastatico, la pillola ha raddoppiato il tempo di sopravvivenza, con minori effetti collaterali…
- ·
20minutos.es
Un ensayo identifica un tratamiento que duplica la supervivencia de pacientes con cáncer de páncreas avanzado
Los pacientes tratados alcanzan una supervivencia media de 13,2 meses frente a los 6,7 de la quimioterapia convencional. En la investigación ha participado el Hospital Clínic de…
- ·
inews.co.uk
Why this new pill for a deadly cancer has doctors excited
The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer
- ·
quotidianodelsud.it
Cancro al pancreas, un nuovo farmaco raddoppia il periodo di sopravvivenza: lo studio - Il Quotidiano del Sud
2 minuti per la lettura (Adnkronos) – Una pillola, presa ogni giorno, può raddoppiare il periodo di sopravvivenza per i pazienti colpiti da cancro al pancreas. Sono i risultati di…
- ·
calabria7.news
Tumore al pancreas, svolta dalla ricerca: il farmaco daraxonrasib raddoppia la sopravvivenza (Calabria 7)
Un nuovo studio clinico sta attirando grande attenzione nella comunità scientifica internazionale per i risultati ottenuti nel trattamento del tumore al
- ·
benzinga.com
Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits
Few cancers have proven as difficult to treat as pancreatic cancer, making any sign of a survival breakthrough a major event for both patients and investors.
- ·
fanpage.it
Tumore al pancreas, pillola daraxonrasib raddoppia la sopravvivenza: “È una svolta, ho pianto quando ho visto i risultati”
Il farmaco daraxonrasib contro il cancro al pancreas ha dimostrato risultati rivoluzionari in un nuovo studio
- ·
newsbytesapp.com
This drug can double survival time for pancreatic cancer patients
A groundbreaking daily pill has been shown to double survival time for patients battling the world's deadliest cancer, marking a major advancement in medical research.
- ·
g4media.ro
STUDIU: Un nou medicament dublează perioada de supraviețuire pentru pacienții diagnosticați cu cancer pancreatic
S-a descoperit că o pastilă poate aproape dubla perioada de supraviețuire pentru pacienții cu cancer pancreatic avansat, experții descriind studiul clinic ca fiind revoluționar.
- ·
virgilio.it
Tumore al pancreas, la nuova cura con compresse di daraxonrasib dà speranza: come funziona la molecola
La molecola daraxonrasib raddoppia la sopravvivenza contro il tumore al pancreas: i dati promettenti dello studio clinico presentati all'Asco
- ·
infobae.com
Cáncer de páncreas: cómo actúa el fármaco experimental que duplicó la supervivencia en uno de los tumores más mortales
Los resultados del ensayo clínico con daraxonrasib se presentaron ayer en la reunión anual de la Sociedad Estadounidense de Oncología Clínica en Chicago. “Representa un cambio de…
- ·
eu.usatoday.com
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who can get it.